Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Fragoso

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Cureus|January 5, 2023
Impact of COVID-19 Pandemic on In-Hospital Mortality in Patients Without SARS-CoV-2 Infection in an Internal Medicine Ward of a Tertiary Care Hospital in PortugalAna Rita Ramalho, Ana Cristina Mendes, Guilherme Camões, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort AnalysisHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
EJNMMI Research|March 13, 2026
Comparison between [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>18</sup>F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancerAlina Toni Küper, Sofia Carrilho Vaz, Kim Magaly Pabst, et al.
European Urology Open Science|June 26, 2023
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy SpecimensChristopher Darr, Pedro Fragoso Costa, Theresa Kahl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2023
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetryPablo Mínguez Gabiña, Katarina Sjögreen Gleisner, Marta Cremonesi, et al.
EJNMMI Research|June 12, 2026
Early timepoint <sup>99m</sup>Tc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosisStephan Settelmeier, Lukas Kessler, Noah Hammersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival DataChristoph Oster, Lukas Kessler, Tobias Blau, et al.
Nuklearmedizin. Nuclear Medicine|April 7, 2022
Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in GermanyAndreas Rinscheid, Tilman Janzen, Babak Alikhani, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cureus|January 5, 2023
Impact of COVID-19 Pandemic on In-Hospital Mortality in Patients Without SARS-CoV-2 Infection in an Internal Medicine Ward of a Tertiary Care Hospital in PortugalAna Rita Ramalho, Ana Cristina Mendes, Guilherme Camões, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort AnalysisHelena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
EJNMMI Research|March 13, 2026
Comparison between [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>18</sup>F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancerAlina Toni Küper, Sofia Carrilho Vaz, Kim Magaly Pabst, et al.
European Urology Open Science|June 26, 2023
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy SpecimensChristopher Darr, Pedro Fragoso Costa, Theresa Kahl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2023
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetryPablo Mínguez Gabiña, Katarina Sjögreen Gleisner, Marta Cremonesi, et al.
EJNMMI Research|June 12, 2026
Early timepoint <sup>99m</sup>Tc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosisStephan Settelmeier, Lukas Kessler, Noah Hammersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival DataChristoph Oster, Lukas Kessler, Tobias Blau, et al.
Nuklearmedizin. Nuclear Medicine|April 7, 2022
Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in GermanyAndreas Rinscheid, Tilman Janzen, Babak Alikhani, et al.
Pageof 7